Matrix metalloproteinases (MMPs) are believed to be pivotal enzymes in the invasion of articular cartilage by synovial tissue in rheumatoid arthritis (RA). Here, we investigated the effects of gene transfer of tissue inhibitors of metalloproteinases (TIMPs) on the invasiveness of RA synovial fibroblasts (RASF) in vitro and in vivo. Adenoviral vectors (Ad) were used for gene transfer. The effects of AdTIMP-1 and AdTIMP-3 gene transfer on matrix invasion were investigated in vitro in a transwell system. Cartilage invasion in vivo was studied in the SCID mouse coimplantation model for 60 days. In addition, the effects of AdTIMP-1 and AdTIMP-3 on cell proliferation were investigated. A significant reduction in invasiveness was demonstrated in vitro as well as in vivo in both the AdTIMP-1-and AdTIMP-3-transduced RASF compared with untransduced SF or SF that were transduced with control vectors. In vitro, the number of invading cells was reduced to 25% (Po0.001) in the AdTIMP-1-transduced cells and to 13% (Po0.0001) in the AdTIMP-3-transduced cells (% of untransduced cells). Cell proliferation was significantly inhibited by AdTIMP-3 and, less, by AdTIMP-1. In conclusion, overexpression of TIMP-1 and TIMP-3 by Ad gene transfer results in a marked reduction of the invasiveness of RASF in vitro and in the SCID mouse model. Apart from the inhibition of MMPs, a reduction in proliferation rate may contribute to this effect. These results suggest that overexpression of TIMPs, particularly TIMP-3 at the invasive front of pannus tissue, may provide a novel therapeutic strategy for inhibiting joint destruction in RA.
Introduction
The invasion of synovial cells into articular cartilage and bone is an important cause of joint destruction in rheumatoid arthritis (RA). 1 Activated synovial fibroblasts (SF) have been shown to be involved in this process by their attachment to the cartilage surface and the release of matrix-degrading enzymes. 2 These locally secreted proteolytic enzymes degrade the articular cartilage at the pannus-cartilage interface and mediate the invasion of synovial cells into the cartilage. Although all classes of proteolytic enzymes seem to be involved, it is generally believed that matrix metalloproteinases (MMPs) are pivotal in cartilage destruction. 3, 4 MMPs are a family of zinc-dependent proteolytic enzymes that have the ability to degrade almost all proteins of the extracellular matrix. MMPs are divided into subgroups including: collagenases (MMP-1, -8, -13), gelatinases (MMP-2, -9), stromelysins (MMP-3, -7, -10, -11, -12), and membrane-type (MT) MMPs (MT1-MMP, MT2-MMP, MT3-MMP, MT4-MMP also termed MMP-14, -15, -16, and -17). MMPs are secreted as proenzymes and activated by serine proteases like plasmin or elastase, or by other MMPs including MMP-3 and MT1-MMP. In rheumatoid synovial tissue, increased amounts of MMPs are expressed. [5] [6] [7] [8] [9] [10] Levels of MMP in the synovium and serum correlate with disease activity 11 and radiographic damage, 12, 13 suggesting that MMPs play a role in the destructive process in RA. Therefore, inhibition of MMPs may be a therapeutic strategy to prevent joint destruction in RA, and the delivery of naturally occurring inhibitors of MMPs may serve as one option for achieving this goal.
Within tissues, MMPs are inhibited by tissue inhibitors of metalloproteinases (TIMPs). Four subtypes of TIMPs have been described, 14 that share some properties, but are distinct in others. TIMP-1, TIMP-2, and TIMP-4 are secreted as soluble factors, while TIMP-3 is associated with the extracellular matrix. Unlike TIMP-1, TIMP-2 and TIMP-3 are effective inhibitors of MT-MMPs. In contrast to the other TIMPs, TIMP-3 is capable of inhibiting the shedding of cell-membrane-anchored proteins such as tumor necrosis factor (TNF) receptor, 15 interleukin-6 receptor, 16 syndecan ectodomains, 17 and of the TNF-a-converting enzyme (TACE). 36 The presence of TIMPs has been shown in RA synovial tissue. 9, 18 Despite an increased expression of TIMPs in RA, 9, 19 proteolytic degradation of the articular cartilage still occurs, suggesting an imbalance between MMP and TIMP activity in favor of the MMPs. Restoring the imbalance between MMP and TIMP activity within the rheumatoid synovium or changing it into a balance in favor of TIMP activity may, therefore, protect the articular cartilage and bone from MMP-mediated degradation.
In the present study, we investigated the effects of overexpression of TIMP-1 or TIMP-3 by adenoviral (Ad) gene transfer on the invasive behavior of human rheumatoid arthritis synovial fibroblasts (RA-SF) in vitro and in the SCID-mouse co-implantation model.
Results
Toxicity and transduction efficacy of AdLacZ-, AdTIMP-1-and AdTIMP-3-transduced RA-SF To study the toxicity of Ad transduction, cell viability after transduction with AdTIMP-1, AdTIMP-3, or AdLacZ in virus concentrations of 100, 200, 500, and 1000 PFU/ml was assessed by measuring mitochondrial enzyme activity. When up to 500 PFU/cell of Ad construct was used, no significant reduction was observed on cell viability of AdTIMP-1 and AdTIMP-3-transduced RA-SF compared with AdLacZ-transduced fibroblasts. When 1000 PFU/cell were used, a 12% reduction of mitochondrial enzyme activity in Ad-TIMP-1-transduced cells (P¼0.02) and a 25% reduction in AdTIMP-3-transduced cells (P¼0.007) was measured, as compared with AdLacZ-transduced cells (not shown). For the in vitro and in vivo invasion experiments, a virus concentration of 300 PFU/cell was chosen. To investigate the transduction efficacy of the Ad constructs, RA-SF were transduced with 300 PFU/cell of a b-galactosidaseencoding adenovirus (AdLacZ). Twenty-four hours after transduction, a transduction efficacy of 67% was achieved, as assessed by counting of blue-stained cells (Figure 1 ).
To investigate gene expression by RA-SF of TIMP-1 and TIMP-3 after Ad gene transfer (300 PFU/cell), RA-SF were transduced with AdTIMP-1 and AdTIMP-3. Using RT-PCR, transgenic TIMP-1 and TIMP-3 mRNA expression was demonstrated 2 days (data not shown) and 60 days after gene transfer as assessed by RT-PCR ( Figure  2a ). TIMP-1 levels in the supernatants of AdTIMP-1-transduced fibroblasts were measured by ELISA. In the conditioned medium of the AdTIMP-1-transduced cells TIMP-1 levels were 57.0 mg/ml at 10 days after transduction and 39.0 mg/ml at 60 days after transduction. TIMP-1 concentrations in the conditioned medium of AdControl-transduced cells were 5.8 mg/ml at 10 days after transduction and 0.1 mg/ml at 60 days after transduction.
MMP-inhibitory activity after AdTIMP-1 and AdTIMP-3 gene transfer
To study whether transduction with AdTIMP-1 or AdTIMP-3 leads to the overexpression of active TIMP-1 and TIMP-3, an MMP activity assay was used. Elevated levels of MMP-inhibitory activity were measured in the cell lysates of AdTIMP-1-and AdTIMP-3-transduced cells. The inhibitory activity in cell lysates of AdTIMP-1-transduced cells was stronger than in those of AdTIMP-3-transduced cells (Figure 2b , white bars). In the conditioned medium of AdTIMP-1-transduced cells MMP inhibitory activity was found, whereas in the In addition, gelatine zymography was performed to investigate whether transduction with AdTIMP-1 or AdTIMP-3 leads to inhibition of the activation of pro-MMP-2. Using this technique the presence of active MMP-2 can be distinguished from latent MMP-2. In the conditioned medium of the untransduced, AdLacZ-, and TIMP-1-transduced fibroblasts both active MMP-2 and pro-MMP-2 was present, whereas in the conditioned medium of AdTIMP-3 transduced fibroblasts pro-MMP-2 was present, but hardly any active MMP-2 ( Figure 2c ).
Effects of AdTIMP-1 and AdTIMP-3 gene transfer on proliferation
Incorporation of
3 H-thymidine in DNA was determined to measure cell proliferation. The proliferation rate of RA-SF transduced with AdTIMP-1 or AdTIMP-3 was significantly reduced compared with AdLacZ-transduced RA-SF, as measured by 3 H-thymidine incorporation. The effect of AdTIMP-3 gene transfer was significantly stronger than that of AdTIMP-1 gene transfer ( Figure 3 ).
Inhibition of matrix invasion in vitro
Invasion of RA-SF in vitro was assessed using a transwell system in which an artificial matrix (Matrigel (a) Expression of transgenic TIMP-1 and TIMP-3 was seen for at least at 60 days. Rheumatoid synovial fibroblasts were cultured after transduction with AdTIMP-1, AdTIMP-3, or the AdControl. Sixty days after transduction, mRNA was isolated and cDNA was generated using reversed transcriptase. The cDNA was amplified by PCR using primer pairs (TIMP-1 forw/Adrev and TIMP-3 forw/Adrev) that reacted specifically with the transgenic TIMP-1 or TIMP-3 and not with the endogenous TIMP-1 and TIMP-3. (b) MMP-2-inhibitory activity was detectable in cell lysates and conditioned medium of AdTIMP-1-and AdTIMP-3-transduced rheumatoid synovial fibroblasts. Cell lysates and conditioned medium samples of AdLacZ, AdTIMP-1-and AdTIMP-3-transduced rheumatoid synovial fibroblasts were diluted 10 and 200 times, respectively, and incubated with active MMP-2 for 120 min. Subsequently, a fluorogenic substrate for MMP-2 was added, and MMPactivity was measured over time. MMP-2 activities are expressed as percent of untransduced controls (n¼3 for all cells). (c) TIMP-3 overexpression inhibited MMP-2 activation. Rheumatoid synovial fibroblasts transduced with AdLacZ, AdTIMP-1, AdTIMP-3, or untransduced cells (control) were cultured in serum-free medium for 2 days in the presence of 5 ng/ml TNF-a to stimulate MT1-MMP expression. Gelatin zymography was performed in the conditioned medium to investigate the presence of active MMP-2. 
Discussion
Invasion of the articular cartilage and bone by hyperplastic synovial tissue leads to destruction of the joints in patients with RA. The involvement of MMPs in this process and the effects of gene transfer of TIMPs were investigated in the present study.
In an in vitro model of invasion, the invasiveness of human RA-SF was reduced significantly by the MMP inhibitor Marimastat, confirming that MMPs mediate this process directly. These findings are in line with the concept that the imbalance in the expression of MMPs and TIMPs by rheumatoid synovial cells at the invasive front of the synovial tissue contributes to cartilage destruction in RA. 20, 19 Since gene transfer of TIMPs may be a way to restore the balance between the expression of MMPs and TIMPs, the effects of gene transfer of AdTIMP-1 and AdTIMP-3 on the invasiveness of RA-SF were studied.
First, the inhibitory properties of TIMP-1 and TIMP-3 overexpression were investigated. Elevated MMP inhibitory activity was demonstrated in the conditioned medium and cell lysates of AdTIMP-1-and AdTIMP-3-transduced RA-SF compared with AdLacZ-transduced fibroblasts. Moreover, overexpression of TIMP-3 by AdTIMP-3 gene transfer inhibited the activation of pro-MMP-2 in the conditioned medium, as shown by gelatin zymography. Pro-MMP-2 is mainly activated at the cell surface by MT-MMP. 21 Therefore, the inhibition of MMP-2 activation in the AdTIMP-3-transduced cells is most likely due to inhibition of MT-MMP. In an in vitro invasion model, the invasion of RA-SF through a Matrigel s or collagen I matrix could be significantly inhibited by both AdTIMP-1 and AdTIMP-3 gene transfer. The results in the SCID mouse in vivo model of cartilage destruction showed also a clear reduction of invasion into the cartilage by RA-SF that were transduced with AdTIMP-1 or AdTIMP-3.
The significant reduction of invasion of RA-SF by overexpression of TIMP-1 suggests that apart from the MT-MMPs a variety of other MMPs are important mediators of invasion. However, the finding that overexpression of TIMP-3 resulted in a significantly stronger reduction of invasion stresses the importance of the properties of TIMP-3 that are distinct from those of TIMP-1. The ability to inhibit MT-MMPs and the association to the extracellular matrix 22 may explain the stronger effects of TIMP-3. The abundant presence of MT-MMPs at the invasive front of the synovial tissue in RA patients compared with the synovial tissues of patients with osteoarthritis or without arthritis 7, 23, 10 supports the view that MT-MMPs play an important role in cartilage destruction in RA. MT-MMPs are capable of degrading cartilage macromolecules including aggrecan 24 and collagen II. 25 However, they also activate other MMPs, such as MMP-2 and MMP-13. 21 Since active MMP-2 and MMP-13 are both implicated in the pathogenesis of joint destruction in RA, 12, 7, 8 the inhibition of the activation of these enzymes by TIMP-3 overexpression may be an efficient way to inhibit MMP-mediated cartilage invasion. The property to bind to extracellular matrix may also contribute to the inhibitory effect of TIMP-3, since it keeps the inhibitor localized to the direct environment of the invasive cells.
To investigate effects of AdTIMP-1 and AdTIMP-3 gene transfer other than inhibition of MMPs that may influence the invasiveness of RA-SF, cell viability and cell proliferation were assessed. Using less than 500 PFU/ TIMP-1 and -3 inhibit cartilage degradation in RA WH van der Lann et al cell, no significant effects of AdTIMP-1 or AdTIMP-3 gene transfer on cell viability were noted. Interestingly, however, cell proliferation was significantly inhibited by AdTIMP-3 gene transfer as compared with AdLacZ gene transfer and to a lesser extent by AdTIMP-1 gene transfer. The effects of TIMP-1 and TIMP-3 overexpression on proliferation appear to differ with cell types. An inhibitory effect of TIMP-1 overexpression on cell proliferation was observed in hepatocytes 26 and of TIMP-3 overexpression in colon carcinoma cells. 27 While TIMP-1 overexpression had no effects on cell proliferation in smooth muscle cells, 28 overexpression of TIMP-3 resulted in an accumulation of these cells in the S and G2/M phase and an increase in apoptosic cell death 3 . The mechanisms by which TIMPs effect the cell cycle are not clear. Since administration of exogenous MMP inhibitors has been shown to reduce tumor growth, it has been suggested that inhibition of proliferation may be caused by inhibition of degradation of extracellular matrix molecules which regulate the cell cycle by cellmatrix interactions. 28 However, this may not explain the inhibition of proliferation in the AdTIMP-1-and Ad-TIMP-3-transduced cells that was observed in the present study, since the cells were cultured in a monolayer on plastic. It has been demonstrated that the inhibitory effects of TIMP-2 overexpression on the Figure 5 Cartilage invasion by rheumatoid synovial fibroblasts is inhibited by TIMP-1 and TIMP-3 gene transfer in the SCID mouse co-implantation model. Rheumatoid synovial fibroblasts, transduced with AdTIMP-1, AdTIMP-3, a mock vector, or untransduced cells were put into a Gelfoam sponge (Sp) and implanted with human articular cartilage under the renal capsule of SCID for 60 days. Then, the implants were removed, and the depth of invasion of rheumatoid synovial fibroblasts was evaluated in paraffin sections using a semiquantitative score. The arrows indicate the invasive front of the implanted rheumatoid synovial fibroblasts: (a) Untransduced rheumatoid synovial fibroblasts (representative picture of n¼3); (b) AdControl transduced rheumatoid synovial fibroblasts (n¼1); (c) AdTIMP-1-transduced rheumatoid synovial fibroblasts (representative picture of n¼2); (d) AdTIMP-3-transduced rheumatoid synovial fibroblasts (representative picture of n¼3) and (e) the depth of invasion of rheumatoid synovial fibroblasts co-implanted with human articular cartilage under the renal capsule of SCID mice was scored using a semiquantitative scoring method. * ¼ Po0.01.
TIMP-1 and -3 inhibit cartilage degradation in RA
WH van der Lann et al proliferation of smooth muscle cells could not be mimicked by the addition of recombinant TIMP-2 to the cell culture, 28 suggesting that the cell cycle effects of overexpression of TIMPs may be caused by intracellular mechanisms. Culturing AdTIMP-1-and AdTIMP-3-transduced RA-SF revealed that transgenic TIMP-1 and TIMP-3 were still expressed after 60 days, suggesting that a large part of the RA-SF survived AdTIMP-1 and AdTIMP-3 transduction. Moreover, for TIMP-1 there was a stable overexpression as measured by ELISA throughout the 60 days culture period. This suggests that the reduced invasion of the AdTIMP-1-and AdTIMP-3-transduced cells observed in the SCID mouse coimplanation model after 60 days was due to stable overexpression of TIMP-1 and TIMP-3 resulting in effective inhibition of MMP-mediated invasion.
The effects of intravenous injection of Ad constructs encoding TIMP-1 has been tested in collagen-induced arthritis (CIA) in mice and in TNF-a-overexpressing mice that develop polyarthritis spontaneously. In TNF-aoverexpressing mice, a reduction of both joint destruction and inflammation by intravenous AdTIMP-1 gene transfer was demonstrated. 29 In contrast, no beneficial effect of TIMP-1 overexpression was noted in CIA. 30 In fact, TIMP-1 overexpression tended to worsen inflammatory scores and joint erosions. This is in contrast to another study that investigated the effects of intravenous injection of recombinant TIMP-1 into mice with CIA. In this study, a decreased incidence of joint erosions was seen in the TIMP-1 treated mice. 31 These conflicting results of TIMP-1 overexpression in arthritis models suggest that the effects of gene transfer with TIMP-1 may depend on the arthritis model, the time when treatment started, and the potential proinflammatory effects of TIMP-1. Although the nature of such proinflammatory effects remain unclear, TIMP-1 gene transfer induced a Th2 response in the CIA model that resulted in an increase in proinflammatory cytokine production. 30 This may provide one explanation for the outcome in the TIMP-1 treated mice in this study. Interestingly, TIMP-1 gene transfer increased the shedding of soluble TNFreceptor (sTNFR), an inhibitor of TNF. While the opposite would have been expected given that MMPs mediate the shedding of sTNFR, this effect of TIMP-1 may be beneficial in the TNF overexpression arthritis model where TNF is the driving force behind both inflammation and joint destruction. The specific in vivo model used in our study lacked an inflammatory component as provided by human T cells or macrophages. Therefore, potential proinflammatory effects of TIMP-1 as noted in the above study were unable to interfere with the observed effects. Although there are no specific data on gene transfer of TIMP-3 in the CIA model, our findings together with other observations 15 may speak in favor of gene transfer of TIMP-3 as an alternative approach. The results presented here show that the invasiveness of RA-SF is effectively inhibited by TIMP-3 overexpression. Moreover, other effects of TIMP-3, such as the reduction of proliferation, may have beneficial effects on synovial inflammation.
In conclusion, overexpression of TIMP-1 and TIMP-3 by Ad gene transfer results in a marked reduction of the invasiveness of RA-SF In vitro and In vitro. In vitro, TIMP-3 overexpression showed a stronger inhibitory effect than TIMP-1, which may be caused by distinct properties of TIMP-3 including the inhibition of MT-MMPs and the binding of TIMP-3 to extracellular matrix molecules. In addition to the inhibition of MMPs, the reduction of proliferation, demonstrated in AdTIMP-3-and, to a lesser extent, in AdTIMP-1-transduced cells, may also contribute to the inhibition of invasion. These results suggest that overexpression of TIMPs, particularly TIMP-3, at the invasive front of the synovial tissue may provide a novel therapeutic strategy to inhibit joint destruction in RA.
Material and methods

Ad vectors
Replication-defective Ad vectors (E1-deleted, CMV promotor) encoding TIMP-1 and TIMP-3 were used for the experiments. As control vectors, a b-galactosidaseencoding Ad construct (AdLacZ) and a construct without an insert (AdControl) were used.
Isolation and culture of RA-SF
Synovial tissues were obtained with informed consent from RA patients who required joint surgery. RA-SF were isolated by collagenase digestion and cultured as described previously. 4 The RA-SF were passaged two or three times before use in the in vitro experiments. For the SCID mouse co-implantation experiment, RA-SF passaged four times were used. A sample of the RA-SF that were implanted in the SCID mice (untransduced cells, cells transduced with AdTIMP-1, AdTIMP-3, or AdControl) were cultured for 60 days in DMEM/F12 supplemented with 10% fetal calf serum (FCS) without passaging the cells.
Transduction
In vitro experiments: RA-SF were seeded in 6-well plates (2 Â 10 5 cells per well) in DMEM/F12 medium with 10% normal human serum (NHS) and 10% newborn calf serum (NCS). After 24 h, the cells were washed and incubated with an Ad vector in 1 ml DMEM/F12 supplemented with 5% NCS or 5% FCS. After overnight incubation, the adenovirus-containing medium was removed. Subsequently, the transduced cells were cultured in DMEM/F12 medium with 10% NHS and 10% NCS for another 24 h before they were trypsinized and used in the experiments. For the toxicity and the proliferation experiments, concentrations of 100, 200, 500 and 1000 PFU/cell were used. For the other in vitro experiments 300 PFU/cell were used.
SCID mouse co-implantation model: 5 Â 10 5 RA-SF were seeded in 75 cm 2 culture flasks and were incubated for 24 h with 300 PFU/cell of AdTIMP-1, AdTIMP-3, or the mock vector in 15 ml DMEM/F12 with 5% FCS. After 24 h, the cells were washed and incubated for 24 h with DMEM/F12 with 10% FCS. Transduction efficacy was assessed in the LacZ-transduced fibroblasts after bgalactosidase staining by assessing the percentage of blue-stained cells by cell counting.
mRNA isolation and reversed transcriptase (RT) PCR
RA-SF, transduced with AdTIMP-1, AdTIMP-3, AdControl, or untransduced cells were cultured after transduction in DMEM/F12 supplemented with 10% NHS and 10% NCS. After 2 days of culture, mRNA was isolated TIMP-1 and -3 inhibit cartilage degradation in RA WH van der Lann et al using the Chomczynski procedure. 32 The RA-SF (transduced with AdTIMP-1, AdTIMP-3, AdControl, or untransduced cells) that were cultured in parallel to the SCID mouse co-implantation experiment were lysed after 60 days of culture. Of these lysates, mRNA was isolated using the TRIZOL s LS Reagent (GibcoBRL, Life Technologies AG, Basel, Switzerland). Of the mRNA isolated, 1 ml was used to generate cDNA using the Reverse Transcription System of Promega (Leiden, The Netherlands). cDNA was amplified by PCR (RoboCycler, Stratagene Europe, Amsterdam, The Netherlands). To specifically detect mRNA of the transgenic TIMP-1 and TIMP-3, primer pairs were designed that recognized TIMP-1 or TIMP-3 in combination with mRNA of the Ad construct that is expressed along with the TIMP-1 or TIMP-3 genes. To detect transgenic TIMP-1, oligonucleotide 5 0 -TCGCGATGCACCTGTGTCCCACC-3 0 , recognizing TIMP-1 cDNA, was used as the forward primer (TIMP-1 forw). To detect transgenic TIMP-3, oligonucleotide 5 0 -AGCAGCGGCAATGACCCCTTG-3 0 , recognizing TIMP-3 cDNA was used as the forward primer (TIMP-3 forw). In both cases oligonucleotide 5 0 -TCTAGCAG-CACGCCATAGTGAC-3 0 , recognizing the DNA of the plasmid that was inserted into the Ad vectors, was used as the reversed primer (Adrev).
Cell viability assessment
RA-SF were seeded in a 24-well plate (2.5 Â 10 4 cells/ well) and incubated with AdTIMP-1, AdTIMP-3, AdLacZ, or AdControl in concentrations of 100, 200, 500 or 1000 PFU/ml. After overnight incubation, the cells were washed and cultured in serum-free DMEM/F12. After 24 h, the cells were washed and incubated for 3 h in 371C with an MTT solution (1 mg MTT/ml PBS; Sigma Chemical Company, St Louis, MO, USA). After 3 h the cells were lysed. Of the lysates 100 ml was transferred to an ELISA-plate and extinction was measured at 540 nm. The experiment was performed in duplicate. The results are expressed as means and standard error of the mean (s.e.m.).
Proliferation assay
RA synovial fibroblasts were seeded at 50% confluency (2.5 Â 10 4 cells/well) in 24-well tissue culture plates in DMEM/Ham's F12 supplemented with 5% NCS. After 24 h, the cells were incubated with AdTIMP-1, AdTIMP-3, or AdLacZ in concentrations of 100, 200, 500 or 1000 PFU/ml. After overnight incubation, the medium was changed, and the cells were incubated with DMEM/ F12 supplemented with 40% NHS for 26 h at 371C and labeled with 1 mCi 3 H-thymidine/well (Amersham Pharmacia Biotech, Little Chalfont, UK) for the last 4 hours. H-thymidine incorporation was measured as described previously. 30 The experiment was performed in quadruplicates. The results are expressed as means and s.e.m.
TIMP-1 measurement
Synovial fibroblasts were cultured after transduction (MOI ¼ 300) with AdTIMP-1 or AdControl for 60 days (5 Â 10 5 cells/ 75 cm 2 ). Every 10 days supernatants were taken and stored at À801C until measurement. TIMP-1 was measured in the supernatants by ELISA (Amersham Pharmacia Biotech, Little Chalfont, UK). The results are expressed as means and s.e.m. The experiment was performed in duplicates.
MMP activity assay
Cell lysates and conditioned medium samples (24 h, serum-free) were incubated with active MMP-2 (final concentrations of 0.5 nM) at 371C for 120 min. Dilutions of the cell lysates (10 Â ) and conditioned media (100 and 200 Â ) were chosen that showed no inhibitory activity in the samples of the untransduced (control) and AdLacZtransduced fibroblasts, but by contrast a clear inhibitory activity was observed in the samples of AdTIMP-1-and/ or AdTIMP-3-transduced fibroblasts. Then, a fluorescent MMP-2-sensitive substrate (TNO 211F, TNO Prevention and Health, Gaubius Laboratory, Leiden, The Netherlands) was added, and directly thereafter MMP activity was measured in a fluorescence multiplate reader (Cytofluor II, Applied Biosystems, Foster City, CA, USA) every 3 min over a 90 min period. The MMP activity was assessed within the time interval of linear increase of MMP activity over time and was defined as fluorescence units per second (FU/s). The results are expressed as the percentage of MMP-2 activity in the samples of the AdLac-Z-transduced cells. The experiment was performed in quadruplicates.
Gelatin zymography
RA-SF were seeded on top of Matrigel s (Collaborative Biochemical Products, Bedford, MA, USA) or collagen I (Vitrogen 100, Celtrix, Santa Clara, CA, USA). The fibroblasts were transduced with AdTIMP-1, AdTIMP-3, or the mock vector as described above. The fibroblasts were cultured for 2 days in DMEM/F12 supplemented with 10% NHS and 10% NCS in the presence of 5 ng/ml TNF-a to stimulate MT1-MMP expression. The medium was washed away and the cells were cultured for two additional days in serum-free DMEM/F12 with 5 ng/ml TNF-a. Then the conditioned medium samples were collected and gelatinolytic activity was assessed by applying the samples to a 10% (w/v) acrylamide gel containing 0.2% (w/v) gelatin as described previously. 34 In vitro invasion model (Figure 1) A Transwell system with polycarbonate filters (6.5 mm diameter, 8 mm pore size; Costar, Cambridge, MA, USA) was used together with Matrigel s or collagen type I. Matrigel s was layered on top of the filters in DMEM/ F12 (37.5 mg/well) and dried overnight at room temperature. The Matrigel s -coated filters were hydrated by DMEM/F12 before use. RA-SF were seeded in 200 ml serum-free DMEM/ F12 on top of the Matrigel s in the upper chamber of the transwell (2 Â 10 4 cells/well). When collagen I was used as a barrier, RA-SF were suspended in a collagen I solution (1.9 mg/ml) on ice. Subsequently, the collagen gelled by incubating the collagen I at 371C. The lower chambers were filled with 900 ml DMEM/F12 supplemented with 10% NHS and 10% NBCS. After 72 h of incubation at 371C in 5% CO 2 / 95% air (v/v) the cells were fixed with 2.5% (v/v) glutaraldehyde and stained with a crystal violet solution (2 g/l). The Matrigel s or collagen I together with the cells on the upper side of the filter were scraped off with cotton swabs. Invasion was determined by the percentage surface area covered by cells as measured by image analysis using an Olympus CK2 inverted microscope equipped with a monochrome CCD camera (MX5). Data TIMP-1 and -3 inhibit cartilage degradation in RA WH van der Lann et al were analyzed using Optimas image analysis software (BioScan Inc., Washington DC, USA). Marimastat (kind gift from E. Bone, British Biotech, Oxford, UK) was added in the upper and lower compartments of the transwells in concentrations of 10, 20, 50, or 100 mg/ml. Alternatively, the cells were transduced with AdTIMP-1, AdTIMP-3 or a control vector before seeding onto the Matrigel s or in the collagen I matrix. The experiment was performed five times using RA-SF (third passage) of five different donors. Every experiment was performed in triplicates. 300 PFU/cell of Ad constructs were used in the invasion experiments. The results are expressed as means and s.e.m.
SCID-mouse co-implantation model
At 48 h after transduction with AdTIMP-1, AdTIMP-3, or a control vector (300 PFU/cell), RA-SF were trypsinized and resuspended in 250 ml DMEM/F12 with 10% FCS and inserted into 2 mm 3 sterile Gelfoam sponges (Pharmacia & Upjohn, Kalamazoo, MI, USA) as described previously. 35, 2 Fresh articular cartilage of the knee was obtained from the pathology department and cut into 2-3 mm 3 pieces. Under sterile conditions, the sponges containing the transduced fibroblasts were coimplanted with the cartilage pieces under the renal capsule in the SCID mice. A total of nine mice were used for the implantations: two mice were implanted with AdTIMP-1-transduced fibroblasts, three mice were implanted with AdTIMP-3-transduced fibroblasts, one mouse received fibroblasts infected with the control vector, and three mice received non-transduced fibroblasts. After 60 days, the implants were removed and paraffin sections were made. The invasion scores was decribed previously. 35 Of every co-implant, the invasion scores were determined by taking the means of the sections with the highest score. Per group the means 7 s.e.m. of these values were calculated.
Statistical analysis
Student's t-tests were performed to calculate statistical differences between the results of the different variables. P-values of less than 0.05 were considered statistically significant.
